Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Light-Activated Drug Unclogs Blocked Arteries

Photonics Spectra
May 1999
Atherosclerosis is the accumulation of fatty plaque in arteries, a major cause of heart attack and stroke. A group of researchers at Stanford University has discovered that a drug commonly used in cancer therapy may be effective in partially dissolving blockages.

Only a few types of cells absorb the drug lutetium texaphyrin. These include cancer cells and a cell that plays a role in the formation of plaque. The cells die only after exposure to high-intensity red light.

The researchers injected lutetium texaphyrin in 16 patients who had blocked leg arteries. A day later they delivered red light through a fiber optic probe, inserted into a small slit in the artery. After four weeks, 12 of the 16 patients experienced a noticeable reduction in plaque deposits.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to Photonics Spectra magazine - FREE!